MCRB
Seres Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.72
+1.42%Leverage
- Debt / equity
- 1.64x
- Net debt / equity
- 1.19x
- Debt / assets
- 0.56x
- Debt / EBITDA
- -1.28x
- Net debt / EBITDA
- -0.93x
Liquidity & coverage
- Current ratio
- 2.11x
- Quick ratio
- 2.11x
- Cash ratio
- 0.78x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $22.3M
Cash & dividend
- FCF / debt
- -0.91x
- Cash flow / debt
- -0.90x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026